Atlas Trials

A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia

Clinical trial NCT07255846 · WITHDRAWN

Trial details

NCT number
NCT07255846
Sponsor
Terremoto Biosciences Inc.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hereditary Hemorrhagic Telangiectasia (HHT)
Start date
2025-12-15
Primary completion
2028-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.